|
ADMA ADMA Biologics Inc 1368514 |
| Balance Sheet |
|
Current Assets
|
$528,203,000.00 |
|
Assets
|
$684,210,000.00 |
|
Current Liabilities
|
$75,757,000.00 |
|
Liabilities
|
$276,002,000.00 |
|
Equity
|
$408,208,000.00 |
|
Shares Out
|
225355228.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$87,788,000.00 |
|
Investing Cash Flow
|
$148,000.00 |
| Market Analysis |
Market Cap
|
$2,199,467,025.28 |
|
Price
|
$9.76 |
|
BVPS
|
1.81 |
|
PB
|
5.39 |
|
EPS
|
0.17 |
|
PE
|
12.90 |
|
PS
|
4.42 |
|
FCF
|
$82,989,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
0.20 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
0.19 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.14 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
0.15 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADMA documents filed with the SEC.
ADMA Filings
Clear
